170
T. Ren et al. / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 97 (2012) 167–175
.7
.6
for 4 h before rotary evaporating to remove solvent and cooling to
room temperature. As-separated yellow crystalline precipitates were
collected by filtration and recrystallized with ethanol-chloroform
(1:3, V/V).
(4Z,40Z)-4,40-(2,20-azanediylbis(ethane-2,1-diyl)bis(azanediyl))-
bis(phenylmethan-1-yl-1-ylidene)bis(3-methyl-1-phenyl-1H-pyr-
azol-5(4H)-one) (1a). APCI-MS (m/z) calcd (M+): 624.8, found:
.5
1b
2b
3b
4b
5b
6b
.4
624.0; IR (KBr, cmꢀ1): 1627 (
mC@N), 1151 (mC–O), 1537, 1498 (mC@C),
.3
3058 (mN–Hꢁ ꢁ ꢁO); 1H NMR (CDCl3) d: 1.34 (s, 6H, 2CH3), 1.6 (b, 1H,
NH), 2.79 (t, 4H, J = 2.8 Hz, CH2–CH2), 3.2 (dd, 4H, J = 5.6, 5.6 Hz,
CH2–CH2), 7.12 (t, 2H, J = 7.1 Hz, Ar–H), 7.36–7.39 (m, 8H, Ar–H),
7.49 (t, 6H, J = 7.5 Hz, Ar–H), 7.99 (d, 4H, J = 8.0 Hz, Ar–H), 11.30
(s, 2H, NH). 13C NMR (CDCl3) d: 166.07, 165.74, 147.97, 139.23,
131.49, 130.50, 129.11, 128.72, 127.59, 124.24, 119.40, 99.80,
48.50, 44.46, 15.40.
.2
.1
0.0
250
(4Z,40Z)-4,40-(2,20-azanediylbis(ethane-2,1-diyl)bis(azanediyl))
bis(phenylmethan-1-yl-1-ylidene)bis(3-methyl-1-p-tolyl-1H-pyr-
azol-5(4H)-one) (2a). APCI-MS (m/z) calcd (M+): 652.8, found:
300
350
400
450
500
Wavelength / (nm)
Fig. 3. UV–Vis Absorption spectra of 1b–6b.
651.2; IR (KBr, cmꢀ1): 1630 (
mC@N), 1156 (mC–O), 1536, 1479 (mC@C),
3038 (mN–Hꢁ ꢁ ꢁO); 1H NMR (CDCl3) d: 1.37 (s, 6H, 2CH3), 2.34 (s, 6H,
2CH3), 2.79 (t, 4H, J = 2.8 Hz, CH2–CH2), 3.2 (dd, 4H, J = 5.6, 3.6 Hz,
CH2–CH2), 7.17 (d, 4H, J = 8.4 Hz, Ar–H), 7.34 (dd, 4H, J = 3.6, 1.6 Hz,
Ar–H), 7.51 (t, 6H, J = 7.5 Hz, Ar–H), 7.85 (d, 4H, J = 8.4 Hz, Ar–H),
11.31 (s, 2H, NH). 13C NMR (CDCl3) d: 165.96, 165.58, 147.69,
136.82, 133.77, 131.51, 130.40, 129.27, 129.13, 127.59, 119.39,
99.87, 48.65, 44.46, 21.08, 15.54.
Table 3
The calculated absorption wavelengths of 1a–5a at the TD-B3LYP/cc-pVDZ level.
Compounds
States
Transition
Absorption
k
f
1a
2a
3a
4a
X1A
(164a)2(165a)2(166a)0
161a ? 166a
(4Z,40Z)-4,40-(2,20-azanediylbis(ethane-2,1-diyl)bis(azanediyl))
bis(phenylmethan-1-yl-1-ylidene)bis(1-(4-chlorophenyl)-
3-methyl-1H-pyrazol-5(4H)-one) (3a). APCI-MS (m/z) calcd (M+):
121A
261A
X1A
266.34 (276.8)a
247.15
0.2241
0.2936
160a ? 167a
(172a)2(173a)2(174a)0
169a ? 174a
101A
201A
X1A
275.04 (275.4)a
255.93
0.1629
0.2865
693.6, found: 693.2; IR (KBr, cmꢀ1): 1626 (
mC@N), 1159 (mC–O),
173a ? 179a
1536, 1492 (
m
C@C), 3066 (mN–Hꢁ ꢁ ꢁO); 1H NMR (CDCl3) d: 1.29 (s,
(180a)2(181a)2(182a)0
177a ? 182a
101A
221A
X1A
275.50(276.0)a
253.29
0.1665
0.2369
6H, 2CH3), 1.46 (b, 1H, NH), 2.81 (t, 4H, J = 2.8 Hz, CH2–CH2), 3.2
(dd, 4H, J = 5.6, 5.6 Hz, CH2–CH2), 7.31 (d, 4H, J = 8.8 Hz, Ar–H),
7.37–7.40 (m, 4H, Ar–H), 7.48–7.54 (m, 6H, Ar–H), 7.98 (d, 4H,
J = 8.8 Hz, Ar–H), 11.24 (s, 2H, NH). 13C NMR (CDCl3) d: 166.18,
165.68, 148.26, 137.89, 131.39, 130.49, 129.11, 128.98, 128.65,
127.54, 120.21, 99.65, 48.28, 44.38, 15.36.
177a ? 185a
(198a)2(199a)2(200a)0
199a ? 200a
31A
297.84
0.2201
0.1925
0.1607
61A
198a ? 201a
282.36 (278.2)a
251.38
241A
X1A
194a ? 201a
5a
(186a)2(187a)2(188a)0
184a ? 188a
51A
384.65
0.1833
0.2719
(4Z,40Z)-4,40-(2,20-azanediylbis(ethane-2,1-diyl)bis(azanediyl)) bis
(phenylmethan-1-yl-1-ylidene)bis(1-(4-bromophenyl)-3-methyl-
1H-pyrazol-5(4H)-one) (4a). APCI-MS (m/z) calcd (M+): 782.5, found:
111A
187a ? 189a
337.76 (340.0)a
a
Experimental values in DMF solution.
782.1; IR (KBr, cmꢀ1): 1626 (
mC@N), 1158 (mC–O), 1536, 1490 (mC@C),
3063 (mN–Hꢁꢁ ꢁO); 1H NMR (CDCl3) d: 1.29 (s, 6H, 2CH3), 1.71 (b, 1H,
NH), 2.81 (t, 4H, J = 2.8 Hz, CH2–CH2), 3.2 (dd, 4H, J = 5.6, 5.6 Hz,
CH2–CH2), 7.37–7.40 (m, 4H, Ar–H), 7.45–7.53 (m, 10H, Ar–H), 7.93
(d, 4H, J = 8.8 Hz, Ar–H), 11.23 (s, 2H, NH). 13C NMR (CDCl3) d:
165.15, 165.69, 148.28, 138.36, 131.54, 131.35, 130.48, 129.09,
127.51, 120.49, 116.71, 99.64, 48.26, 44.37, 15.35.
Table 4
The calculated absorption wavelengths of 1b–6b at the TD-B3LYP/cc-pVDZ level.
Compounds
States
Transition
Absorption
k
f
1b
2b
X1A
(176a)2(177a)2(178a)0
173a ? 179a
(4Z,40Z)-4,40-(2,20-azanediylbis(ethane-2,1-diyl)bis(azanediyl))
bis(phenylmethan-1-yl-1-ylidene)bis(3-methyl-1-(4-nitrophenyl)
-1H-pyrazol-5(4H)-one) (5a). APCI-MS (m/z) calcd (M+): 714.7,
141A
X1A
268.90 (276.8)a
0.1428
(184a)2(185a)2(186a)0
182a ? 187a
121A
301A
X1A
272.15 (276.0)a
252.39
0.1303
0.3179
found: 714.4; IR (KBr, cmꢀ1): 1636 (
mC@N), 1158 (mC–O), 1539,
182a ? 191a
C@C), 3197 (mN–Hꢁ ꢁ ꢁO); 1H NMR (CDCl3) d: 1.21 (s, 6H,
3b
4b
5b
6b
(192a)2(193a)2(194a)0
189a ? 195a
1496 (
m
211A
311A
X1A
270.40 (284.0)a
255.62
0.2680
0.1769
2CH3), 2.12 (b, 1H, NH), 2.87 (t, 4H, J = 2.9 Hz, CH2–CH2), 3.25 (m,
4H, CH2–CH2), 7.43–7.46 (m, 4H, Ar–H), 7.54–7.57 (m, 6H, Ar–H),
8.19–8.26 (m, 8H, Ar–H), 11.23 (s, 2H, NH). 13C NMR (CDCl3) d:
166.58, 149.83, 144.51, 142.99, 131.29, 130.75, 129.22, 127.54,
124.75, 117.75, 99.46, 53.59, 47.95, 44.44, 15.39.
184a ? 194a
(210a)2(211a)2(212a)0
208a ? 213a
201A
311A
X1A
271.64 (287.0)a
256.19
0.3036
0.2207
204a ? 212a
(198a)2(199a)2(200a)0
195a ? 201a
91A
303.48 (340.6)a
277.05
0.3081
0.1631
(4Z,40Z)-4,40-(1,12-diphenyl-2,5,8,11-tetraazadodecane-1,12-
241A
X1A
191a ? 200a
192a)2(193a)2(194a)0
187a ? 194a
diylidene)bis(3-methyl-1-phenyl-1H-pyrazol-5(4H)-one)
(1b).
APCI-MS (m/z) calcd (M+): 667.8, found: 667.4; IR (KBr, cmꢀ1):
241A
311A
265.61 (281.0)a
254.59
0.2291
0.1345
C@C), 3059 (mN–Hꢁ ꢁ ꢁO); 1H
186a ? 194a
1629 (
m
C@N), 1151 (
mC–O), 1536, 1499 (
m
a
NMR (CDCl3) d: 1.41 (d, 6H, J = 16 Hz, 2CH3), 1.80 (b, 1H, NH),
2.44 (s, 2H, CH2), 2.55 (b, 1H, NH), 2.74–2.84 (m, 6H, 3CH2), 3.21
(s, 4H, CH2–CH2), 7.12 (t, 2H, J = 7.1 Hz, Ar–H), 7.22 (d, 2H,
J = 7.2 Hz, Ar–H), 7.35–7.48 (m, 10H, Ar–H), 7.54 (s, 2H, Ar–H),
8.02 (t, 4H, J = 8.0 Hz, Ar–H), 11.26 (d, 2H, NH). 13C NMR (CDCl3)
Experimental values in DMF solution.
amount of amine (4 mmol of diethylenetriamine (DETA) or triethyl-
enetetramine (TETA)). Resultant mixturewas refluxed ina water bath